Form 4: BioLife Solutions Executive Sarah Aebersold Reports Stock Grants

Sarah Aebersold, Chief Human Resources Officer of BioLife Solutions, reports the acquisition of common stock through restricted stock grants.

Summary

• On March 18, 2025, Sarah Aebersold, Chief Human Resources Officer of BioLife Solutions Inc., reported the acquisition of 15,279 shares of common stock through a restricted stock grant.
• These shares were granted under the 2023 Omnibus Performance Incentive Plan and vest 25% on the first anniversary of the grant date, followed by quarterly installments over the next 12 quarters.
• Additionally, Ms. Aebersold acquired 21,789 shares of common stock through a restricted stock grant under the 2013 Performance Incentive Plan.
• These shares vested at 175% of the reported number based on BioLife Solutions' total shareholder return from January 1, 2023, to December 31, 2024, compared to its peers.
• Following these transactions, Ms. Aebersold beneficially owns 85,865 shares of BioLife Solutions common stock directly.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed neutrally to positively as it aligns management with shareholder interests.

Positives

• The grants of restricted stock align Ms. Aebersold's interests with those of the shareholders, incentivizing her to contribute to the company's long-term success.
• The vesting schedules of the grants encourage continued service and commitment from Ms. Aebersold.

Industry Context

Stock grants to executives are a common practice in the biotechnology industry to incentivize performance and align management's interests with those of shareholders.

Comparison to Industry Standards

• Stock grants are a typical component of executive compensation packages in publicly traded companies, particularly in the biotech sector.
• Companies like Thermo Fisher Scientific, Danaher, and Sartorius also utilize stock-based compensation to incentivize their executives.
• The vesting schedules and performance metrics associated with these grants are often tailored to the specific goals and priorities of the company.

Stakeholder Impact

• Shareholders may view the stock grants positively as they incentivize management to improve company performance.
• Employees may see the grants as a sign of the company's commitment to rewarding its executives.

Key Dates

Keywords

BioLife Solutions, BLFS, Sarah Aebersold, restricted stock, stock grant, beneficial ownership, Form 4, Chief Human Resources Officer, shareholder return, vesting